The primary objective of this study was to determine to what extent the new European
guidelines for lipid values1 were achieved in general practice in patients treated with a …

The review by Smith and Grundy (1) of the American College of Cardiology/American Heart
Association Cholesterol Treatment Guideline is helpful, but recommendations for statin …

Background In Belgium, regulations restrict the reimbursement of statins to patients with total
serum cholesterol above 250 mg/dl (6.41 mmol/l) after a three-month lipid-lowering diet. We …

Background Patients at risk for cardiovascular disease require medical treatment to optimise
their lipid profile. Failure to reach optimal lipid levels contributes significantly to the residual …

Objective: To study trends in the use of lipid lowering drugs in the UK, and to assess which
patient factors influence prescribing. Methods: Routinely collected computerised medical …

The discovery of statins caused a revolution in the field of lipid intervention. Statins are drugs
with a good safety profile. Their clinical benefit has been extensively documented in primary …

BACKGROUND: Many adults are not at recommended lipid levels and the extent of
treatment of dyslipidemia remains poor. We investigated the burden of cardiovascular risk …

Aims We sought to evaluate physicians' opinions and practices in lipid management.
Methods and results A web-based survey by the European Society of Cardiology (ESC) and …

Recent guidelines for cholesterol management proposed by the American College of
Cardiology (ACC) and American Heart Association (AHA) recommended statin therapy for …

Background Although statins are widely used to reduce low density lipoprotein cholesterol
(LDL-C), there is little information about patient profiles, treatment patterns and goal …